Third, Fava concludes, excessive reliance on checklist criteria is likely to “impoverish the clinical process” and clinical ...

Depression affects 280 million people worldwide. The mental illness has been proven to lead to changes in eating behavior. Researchers have discovered that although patients with depression generally ...

OYE Therapeutics has been authorized to initiate clinical development of its OYE-101 caffeine injection after the U.S. FDA cleared its Investigational New Drug applications. OYE-101 is a novel ...

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...

Solvonis Therapeutics PLC (LSE:SVNS) chief scientific officer Professor David Nutt talked with Proactive's Stephen Gunnion ...

In a first, this week the U.S. Food and Drug Administration approved a brain stimulation device designed to treat depression at home. The approval of the first such device for home depression ...

Lipocine expects trial data to support a 505(b)(2) new drug application submission for LPCN 1154 in 2026.

Lipocine ( (LPCN)) has shared an announcement. On January 20, 2026, Lipocine announced it has completed enrollment and dosing of 90 patients in its Phase 3 clinical trial of LPCN 1154, an oral ...

Depression, one of the most prevalent mental health disorders worldwide, is characterized by persistent feelings of sadness, impaired daily functioning and a loss of interest in daily activities, ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major ...

Researchers looked at 30 depression symptoms in middle-aged people to see if any were associated with dementia later in life. They found six that stood out. A recent study linked certain symptoms of ...

An in-home headset that allows people with depression to send mild electrical current to their brains has been cleared by the Food and Drug Administration, in what medical experts consider a milestone ...